JPH0585531B2 - - Google Patents

Info

Publication number
JPH0585531B2
JPH0585531B2 JP58121756A JP12175683A JPH0585531B2 JP H0585531 B2 JPH0585531 B2 JP H0585531B2 JP 58121756 A JP58121756 A JP 58121756A JP 12175683 A JP12175683 A JP 12175683A JP H0585531 B2 JPH0585531 B2 JP H0585531B2
Authority
JP
Japan
Prior art keywords
alkylated
fab fragment
ulcer
fab
ulcers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58121756A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6013716A (ja
Inventor
Masakazu Iwai
Kazumasa Yokoyama
Tsunekazu Fukushima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Priority to JP58121756A priority Critical patent/JPS6013716A/ja
Priority to CA000457425A priority patent/CA1260828A/en
Priority to DE8484107666T priority patent/DE3474672D1/de
Priority to EP84107666A priority patent/EP0131836B1/en
Priority to ES533908A priority patent/ES8605378A1/es
Publication of JPS6013716A publication Critical patent/JPS6013716A/ja
Priority to US06/827,209 priority patent/US4748157A/en
Priority to US07/163,732 priority patent/US4849404A/en
Publication of JPH0585531B2 publication Critical patent/JPH0585531B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP58121756A 1983-07-04 1983-07-04 消化器潰瘍治療予防剤 Granted JPS6013716A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP58121756A JPS6013716A (ja) 1983-07-04 1983-07-04 消化器潰瘍治療予防剤
CA000457425A CA1260828A (en) 1983-07-04 1984-06-26 Therapeutic and prophylactic agent for gastrointestinal ulcers
DE8484107666T DE3474672D1 (en) 1983-07-04 1984-07-02 Alkylated fab or fc fragments of human igg, process for their preparation and pharmaceutical compositions
EP84107666A EP0131836B1 (en) 1983-07-04 1984-07-02 Alkylated fab or fc fragments of human igg, process for their preparation and pharmaceutical compositions
ES533908A ES8605378A1 (es) 1983-07-04 1984-07-02 Un procedimiento para preparar una composicion terapeutica que contiene un fragmento fab o fa alquilado de inmunoglobulina humana.
US06/827,209 US4748157A (en) 1983-07-04 1986-02-04 Composition for gastrointestinal ulcers
US07/163,732 US4849404A (en) 1983-07-04 1988-03-03 Therapeutic and prophylactic agent for gastrointestinal ulcers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58121756A JPS6013716A (ja) 1983-07-04 1983-07-04 消化器潰瘍治療予防剤

Publications (2)

Publication Number Publication Date
JPS6013716A JPS6013716A (ja) 1985-01-24
JPH0585531B2 true JPH0585531B2 (en]) 1993-12-07

Family

ID=14819105

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58121756A Granted JPS6013716A (ja) 1983-07-04 1983-07-04 消化器潰瘍治療予防剤

Country Status (1)

Country Link
JP (1) JPS6013716A (en])

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5724311A (en) * 1980-07-18 1982-02-08 Green Cross Corp:The Treating and preventing agent for ulcer of digestive organ

Also Published As

Publication number Publication date
JPS6013716A (ja) 1985-01-24

Similar Documents

Publication Publication Date Title
US4348384A (en) Pharmaceutical composition for oral administration containing coagulation factor VIII or IX
Konturek et al. Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effects of aspirin and paracetamol.
US4405596A (en) Pharmaceutical preparations for and treatment procedures involving increasing plasma bicarbonate level
US4748157A (en) Composition for gastrointestinal ulcers
JPH03366B2 (en])
US6187803B1 (en) Drug preparation for oral administration
JPS6314728A (ja) 肝障害の予防、治療剤
JPS62255430A (ja) 哺乳動物の脈管病を治療する方法
JPH0585531B2 (en])
JPH0361655B2 (en])
UA61955C2 (en) Novel salts of bpc-peptides with organoprojective activity, a process for preparing and use thereof in therapy
JPH0148249B2 (en])
CA2195863C (en) Therapeutic drug for endotoxin blood symptom and multi-organ failure induced thereby
JPH06504290A (ja) シュウ酸カルシウム結石病の治療用化合物および医薬組成物
JPS6238329B1 (en])
US4591504A (en) Human leucocyte pepsin-like enzyme as a therapeutic agent for treating allergic disorders and immune complex diseases
JPH0361654B2 (en])
JPH0643343B2 (ja) 免疫調節剤
US4271150A (en) Urokinase preparation for oral administration
JPS6237612B2 (en])
JPH03851B2 (en])
JPH0132804B2 (en])
JPH04971B2 (en])
CA2000650A1 (en) Product and process for the treatment and prevention of intravascular thrombi and atherosclerosis
JPS61134312A (ja) 移植免疫抑制剤並びに抗アレルギ−剤